Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CREB-binding Protein Bromodomain
- Molecular classification
- Bromodomain, Epigenetic regulator, Histone modification reader
01
Overview
The bromodomain of CREB-binding protein (CBP) is a protein module that recognizes and binds to acetylated lysine residues on histones and other proteins. This interaction facilitates chromatin remodeling and transcriptional activation. It is a therapeutic target for diseases involving epigenetic dysregulation.
- Other names
- CBP BromodomainCREBBP Bromodomain
02
Mechanism of action
Inhibition of bromodomain-acetylated lysine interaction
03
Biological functions
Chromatin remodelingTranscriptional coactivationEpigenetic regulation
04
Disease associations
CancerMetabolic disordersNeurological disorders
05
Interacting drugs
IACS‑70654
2 more in the full profile.
Beyond the preview
Go deeper on CREB-binding Protein Bromodomain.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Follow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Compare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Investigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Explore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Connect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CREB-binding Protein Bromodomain.